Rebecca Maki

Rebecca Maki serves as the Vice President and Head of Quality & Compliance at Apollo Therapeutics since March 2024. Prior roles include Executive Director of GXP Quality Systems & Compliance at Seres Therapeutics, where Rebecca managed compliance programs across GMP, GCP, and R&D. At Biogen, experience spans multiple leadership positions, including orchestrating inspection readiness strategies and serving as a regulatory liaison during inspections. Previous roles at Alexion Pharmaceuticals involved overseeing quality assurance operations and enhancing GMP training programs, while earlier positions at Lonza and Millennium Pharmaceuticals focused on documentation and purification processes. Rebecca holds a Bachelor of Science in Biology/Biotechnology from UMass Boston and additional education in Biotechnology from various institutions, including Harvard Extension School.